HE Shuai,ZONG Huiying,LI An’an,et al.Application and prospect of artificial intelligence and population pharmacokinetics in personalized medication after organ transplantation[J].ZHONGGUO YAOFANG,2025,36(14):1813-1818.
HE Shuai,ZONG Huiying,LI An’an,et al.Application and prospect of artificial intelligence and population pharmacokinetics in personalized medication after organ transplantation[J].ZHONGGUO YAOFANG,2025,36(14):1813-1818. DOI: 10.6039/j.issn.1001-0408.2025.14.22.
Application and prospect of artificial intelligence and population pharmacokinetics in personalized medication after organ transplantation
Artificial intelligence (AI) and population pharmacokinetics (PPK) technologies have demonstrated significant potential in the personalized medication of immunosuppressants after organ transplantation
enabling precise prediction of drug dosages. This article provides a comprehensive review of the application status of AI and PPK in the individualized administration of immunosuppressants after organ transplantation, focuses on monitoring blood drug concentration, predicting efficacy/adverse reactions, and establishing individualized dosing models for organ transplant recipients after immunosuppressant administration, and analyzes and compares the application characteristics of different methods in different organ transplant patients as well as the integration and future development of AI and PPK technologies. AI and PPK technologies can not only significantly reduce the dependence on human resources, but also greatly improve the level of individualized treatment of immunosuppressants after organ transplantation, and reduce the discomfort and burden caused by frequent blood concentration monitoring to patients.
TANG J , LIU R , ZHANG Y L , et al . Application of machine-learning models to predict tacrolimus stable dose in renal transplant recipients [J ] . Sci Rep , 2017 , 7 : 42192 .
ZHANG Q W , TIAN X K , CHEN G , et al . A prediction model for tacrolimus daily dose in kidney transplant recipients with machine learning and deep learning techniques [J ] . Front Med(Lausanne) , 2022 , 9 : 813117 .
MAO J J , CHEN Y H , XU L Y , et al . Applying machine learning to the pharmacokinetic modeling of cyclosporine in adult renal transplant recipients:a multi-method comparison [J ] . Front Pharmacol , 2022 , 13 : 1016399 .
TAN S B , KUMAR K S , TRUONG A T L , et al . Com-paring the performance of multiple small-data personalized tacrolimus dosing models for pediatric liver transplant:a retrospective study [J ] . Annu Int Conf IEEE Eng Med Biol Soc , 2023 , 2023 : 1 - 4 .
YOON S B , LEE J M , JUNG C W , et al . Machine-learning model to predict the tacrolimus concentration and suggest optimal dose in liver transplantation recipients:a multicenter retrospective cohort study [J ] . Sci Rep , 2024 , 14 ( 1 ): 19996 .
SONG X W , LIU F H , GAO H E , et al . Compare the performance of multiple machine learning models in pre-dicting tacrolimus concentration for infant patients with living donor liver transplantation [J ] . Pediatr Transplant , 2023 , 27 ( 1 ): e14379 .
LECLERC V , BLEYZAC N , CERAULO A , et al . A decision support tool to find the best cyclosporine dose when switching from intravenous to oral route in pediatric stem cell transplant patients [J ] . Eur J Clin Pharmacol , 2020 , 76 ( 10 ): 1409 - 1416 .
CHOSHI H , MIYOSHI K , TANIOKA M , et al . Long short-term memory algorithm for personalized tacrolimus dosing:a simple and effective time series forecasting approach post-lung transplantation [J ] . J Heart Lung Transplant , 2025 , 44 ( 3 ): 351 - 361 .
SONG L , HUANG C R , PAN S Z , et al . A model based on machine learning for the prediction of cyclosporin A trough concentration in Chinese allo-HSCT patients [J ] . Expert Rev Clin Pharmacol , 2023 , 16 ( 1 ): 83 - 91 .
CHEN B , SHI H Q , LIU X X , et al . Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients [J ] . J Clin Pharm Ther , 2017 , 42 ( 6 ): 679 - 688 .
TENG F , ZHANG W Y , WANG W , et al . Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients [J ] . Biopharm Drug Dispos , 2022 , 43 ( 2 ): 76 - 85 .
CHEN L Z , YANG Y Y , WANG X B , et al . Wuzhi capsule dosage affects tacrolimus elimination in adult kidney transplant recipients,as determined by a population pharmacokinetics analysis [J ] . Pharmgenomics Pers Med , 2021 , 14 : 1093 - 1106 .
PHARMD O C , PHD D B , et al . Tacrolimus population pharmacokinetics and multiple CYP3A5 genotypes in black and white renal transplant recipients [J ] . J Clin Pharmacol , 2018 , 58 ( 9 ): 1184 - 1195 .
ANDREWS L M , HESSELINK D A , VAN SCHAIK R N , et al . A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients [J ] . Br J Clin Pharmacol , 2019 , 85 ( 3 ): 601 - 615 .
LLOBERAS N , GRINYÓ J M , COLOM H , et al . A prospective controlled,randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian prediction [J ] . Kidney Int , 2023 , 104 ( 4 ): 840 - 850 .
CAI X J , SONG H Z , JIAO Z , et al . Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients [J ] . Eur J Pharm Sci , 2020 , 152 : 105448 .
LIU X L , GUAN Y P , WANG Y , et al . Population pharmacokinetics and initial dosage optimization of tacrolimus in pediatric hematopoietic stem cell transplant patients [J ] . Front Pharmacol , 2022 , 13 : 891648 .
PRZEPIORKA D , BLAMBLE D , HILSENBECK S , et al . Tacrolimus clearance is age-dependent within the pedia-tric population [J ] . Bone Marrow Transplant , 2000 , 26 ( 6 ): 601 - 605 .
JACOBSON P A , NG J , GREEN K G , et al . Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation [J ] . Biol Blood Marrow Transplant , 2003 , 9 ( 5 ): 304 - 311 .
FU Q , JING Y , LIU MR G , et al . Machine learning-based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients [J ] . J Clin Pharm Ther , 2022 , 47 ( 5 ): 600 - 608 .
PASCHIER A , DESTERE A , MONCHAUD C , et al . Tacrolimus population pharmacokinetics in adult heart transplant patients [J ] . Br J Clin Pharmacol , 2023 , 89 ( 12 ): 3584 - 3595 .
YANG S Y , WEI J , PAN X Q , et al . Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients:a population pharmacokinetic approach [J ] . Eur J Clin Pharmacol , 2024 , 80 ( 9 ): 1409 - 1420 .
WOILLARD J B , LABRIFFE M , PRÉMAUD A , et al . Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models:the example of tacrolimus [J ] . Pharmacol Res , 2021 , 167 : 105578 .
WANG Y P , LU X L , SHAO K , et al . Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine lear-ning in Chinese renal transplant recipients [J ] . Front Pharmacol , 2024 , 15 : 1389271 .
HU K , HE S M , ZHANG C , et al . Optimizing the initial tacrolimus dosage in Chinese children with lung transplantation within normal hematocrit levels [J ] . Front Pediatr , 2024 , 12 : 1090455 .
HOU J N , YANG S Y , LIU W , et al . Tacrolimus population pharmacokinetic model-informed precision dosing in adult liver transplant patients [J/OL ] . Naunyn Schmiedebergs Arch Pharmacol , 2025 [ 2025-03-01 ] . https://pubmed.ncbi.nlm.nih.gov/40029388/ https://pubmed.ncbi.nlm.nih.gov/40029388/ . DOI: 10.1007/s00210-025-03982-7 http://dx.doi.org/10.1007/s00210-025-03982-7 .